# GLUT4 localisation with the plasma membrane is unaffected by an increase in plasma free fatty acid availability

**Authors:** J. S. Barrett, J. A. Strauss, L. S. Chow, S. O. Shepherd, A. J. M. Wagenmakers, Y. Wang

PMC · DOI: 10.1186/s12944-024-02079-z · Lipids in Health and Disease · 2024-04-02

## TL;DR

Elevated free fatty acids do not affect GLUT4 localization at the plasma membrane during insulin stimulation, suggesting glucose uptake remains unaffected.

## Contribution

Demonstrates that increased free fatty acid availability does not impair GLUT4 membrane localization during insulin stimulation.

## Key findings

- GLUT4 localisation with the plasma membrane increased during a hyperinsulinaemic-euglycaemic clamp.
- Elevated free fatty acid availability did not alter GLUT4 membrane localisation.
- Trained individuals had more small GLUT4 spots at baseline compared to sedentary individuals.

## Abstract

Insulin-stimulated glucose uptake into skeletal muscle occurs via translocation of GLUT4 from intracellular storage vesicles to the plasma membrane. Elevated free fatty acid (FFA) availability via a lipid infusion reduces glucose disposal, but this occurs in the absence of impaired proximal insulin signalling. Whether GLUT4 localisation to the plasma membrane is subsequently affected by elevated FFA availability is not known.

Trained (n = 11) and sedentary (n = 10) individuals, matched for age, sex and body mass index, received either a 6 h lipid or glycerol infusion in the setting of a concurrent hyperinsulinaemic-euglycaemic clamp. Sequential muscle biopsies (0, 2 and 6 h) were analysed for GLUT4 membrane localisation and microvesicle size and distribution using immunofluorescence microscopy.

At baseline, trained individuals had more small GLUT4 spots at the plasma membrane, whereas sedentary individuals had larger GLUT4 spots. GLUT4 localisation with the plasma membrane increased at 2 h (P = 0.04) of the hyperinsulinemic-euglycemic clamp, and remained elevated until 6 h, with no differences between groups or infusion type. The number of GLUT4 spots was unchanged at 2 h of infusion. However, from 2 to 6 h there was a decrease in the number of small GLUT4 spots at the plasma membrane (P = 0.047), with no differences between groups or infusion type.

GLUT4 localisation with the plasma membrane increases during a hyperinsulinemic-euglycemic clamp, but this is not altered by elevated FFA availability. GLUT4 appears to disperse from small GLUT4 clusters located at the plasma membrane to support glucose uptake during a hyperinsulinaemic-euglycaemic clamp.

## Linked entities

- **Genes:** SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517]
- **Chemicals:** glucose (PubChem CID 5793)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}
- **Diseases:** hyperinsulinemic-euglycemic (MESH:D044903)
- **Chemicals:** glycerol (MESH:D005990), lipid (MESH:D008055), glucose (MESH:D005947), FFA (MESH:D005230)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10986142/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10986142/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC10986142/full.md

---
Source: https://tomesphere.com/paper/PMC10986142